David Zaccardelli Archives

Press ESC key to close search

Oxford Finance and Hercules Capital Provide $400MM Debt Facility to Verona Pharma

Biopharmaceutical company Verona Pharma entered into a debt financing facility providing the company with access to up to $400 million from funds managed by Oxford Finance and Hercules Capital.

Oxford Finance Provides $150MM Debt Financing to Verona Pharma

Verona Pharma entered into a debt financing facility providing the company with access to up to $150 million from Oxford Finance. The $150 million debt facility replaces the existing $30 million facility with Silicon Valley Bank.

October 17, 2022 Adam K. Soller | David Zaccardelli | Oxford Finance | Silicon Valley Bank | Verona Pharma Ian Koplin

Silicon Valley Bank Provides Verona Pharma with $30MM in Debt Financing

Silicon Valley Bank entered an agreement to provide a debt financing facility for up to $30 million for Verona Pharma, a clinical-stage biopharmaceutical company focused on respiratory diseases.

November 23, 2020 David Zaccardelli | Silicon Valley Bank | Verona Pharma Ellie Delany

<img width="200" src="https://www.abfjournal.com/wp-content/uploads/2020/02/abfj-logo-web-header1-blue.png" alt="ABFJournal" />

Tag Archives: David Zaccardelli

Oxford Finance and Hercules Capital Provide $400MM Debt Facility to Verona Pharma

Oxford Finance Provides $150MM Debt Financing to Verona Pharma

Silicon Valley Bank Provides Verona Pharma with $30MM in Debt Financing